drugset / Trial / NCT05095532

Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

NCT05095532

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a clinical trial for chronic pancreatitis (CP) patients undergoing total pancreatectomy with islet autotransplantation (TP-IAT). Participants will be randomized to either bone marrow-derived mesenchymal stem cells (MSCs) or control with the standard of care. Participants will be followed for one-year post-transplant.

Timeline

Start
2021-12-01
Primary completion
2027-06-30
Completion
2027-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cell Cell therapy 2e+07 cells
Subject Mesenchymal stem cell Cell therapy 5e+07 cells

Indications